New research reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The research is from Boston University School of Medicine (BUSM). The study, published in the iProceedings of the National Academies of Sciences/i, indicates the importance of continuing to explore B cells as a therapeutic target to treat these diseases. Barbara Nikolajczyk, PhD, associate professor of microbiology at BUSM, is the study's senior ...
View the Original article
Sunday, 17 March 2013
Therapeutic Targets to Alter Inflammation, Type 2 Diabetes Revealed By BUSM Study
Labels:
Alter,
Diabetes,
Inflammation,
Revealed,
Study,
Targets,
Therapeutic
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment